Abstract: A method capable of accurately measuring, in an object including a columnar shaft section and a tabular section projecting outward radially beyond an outer circumferential surface of the shaft section, a distribution of residual stress near a fillet surface interconnecting the shaft section and the tabular section. The method includes repeating a measurement cycle, which includes cutting the object to form a new cutting surface and measuring residual stress in a plurality of parts on the cutting surface. The cutting surface is a conical or cylindrical surface concentric with the axis of the shaft section, being through a reference position unchanged in the repeated measurement cycle. The reference position is desirably the center position of an arc of the fillet surface having the largest diameter on the central longitudinal cross-section of the object.

Abstract: The pharmaceutical injection device of the present invention comprises a cartridge holder, a main case, a piston, a motor, an opening component, an open/closed detection switch, and a controller. The motor drives the piston in either an insertion direction in which the piston is inserted into a pharmaceutical cartridge, or a pull-out direction in which the piston is pulled out of the pharmaceutical cartridge. The opening component opens the cartridge holder in conjunction with the movement of the piston in the pull-out direction. The open/closed detection switch detects whether the cartridge holder is open or closed. When the open/closed detection switch detects that the cartridge holder is open, the controller controls the motor so as to stop the piston.

Abstract: A shunt resistor according to the present invention includes a pair of electrode plates spaced apart from each other in a plate surface direction and a resistive alloy plate that connects the pair of electrode plates and that has a predetermined set resistance value. A surface of the resistive alloy plate is provided with a visually recognizable character string pattern that is formed by laser processing and that indicates the set resistance value of the resistive alloy plate, and a surface area and a carving depth of the character string pattern are set in such a manner that the resistive alloy plate has the set resistance value.

Abstract: Provided are an ultrasonic measurement apparatus, an ultrasonic imaging apparatus and an ultrasonic measurement method that achieve an increase in processing speed together with an increase in resolution and are user friendly. An image is generated by adding together, with a weight having a fixed value, reception signals obtained by ultrasonic echoes being received by an ultrasonic element array, and an area of interest is set within the area in which the generated image is to be displayed. When an area of interest is acquired, the reception signals received by the ultrasonic element array are added together with weights that depend on the reception signals, with respect to data forming the basis of the image to be displayed in the area of interest, and image generation is performed.

Abstract: A pharmaceutical injection device may comprise a main body case in the interior of which a pharmaceutical syringe can be mounted; a drive means that is provided inside the main body case and pushes out the pharmaceutical inside the pharmaceutical syringe through a syringe needle; a cover that opens and closes an opening on the side of the main body case where the syringe needle is mounted; an outside air temperature sensor that measures a first temperature, which is the temperature outside the main body case; a display component; and a controller that controls the drive means and the display component and acquires the first temperature at predetermined intervals. When the cover is closed, the controller causes the display component to display information about the storage state of the pharmaceutical in the mounted pharmaceutical syringe on the basis of the first temperature.

Abstract: The present invention relates to a transfected mammalian host cell whose ability to secrete a foreign protein has been enhanced by using a foreign gene expression vector having a promoter derived from a human gene, and a method for producing the foreign protein using the host cell. A method for enhancing the production of a foreign protein to be used in a pharmaceutical protein product in a host cell such as a cultured mammalian cell is provided. A promoter derived from a human gene having a promoter activity higher than that of a cytomegalovirus (CMV) promoter in a host cell such as a cultured mammalian cell is provided.

Abstract: A shunt resistor according to the present invention includes a pair of electrode plates spaced apart from each other in a plate surface direction and a resistive alloy plate that connects the pair of electrode plates and that has a predetermined set resistance value. A surface of the resistive alloy plate is provided with a visually recognizable character string pattern that is formed by laser processing and that indicates the set resistance value of the resistive alloy plate, and a surface area and a carving depth of the character string pattern are set in such a manner that the resistive alloy plate has the set resistance value.

Abstract: A printer has a print head, a cable harness connected to the print head, a head bracket detachably installed with the print head, a platen roller provided to face the print head, and a storage casing provided in one side of a feeding path and provided with a storage space in which the cable harness can be stored.

Abstract: A printer has a print head, a cable harness connected to the print head, a head bracket detachably installed with the print head, a platen roller provided to face the print head, and a storage casing provided in one side of a feeding path and provided with a storage space in which the cable harness can be stored.

Abstract: To provide a capacitor capable of having a larger capacity than a case where only a solid electrolyte is simply used as a dielectric material of the capacitor. The capacitor (1) includes a solid electrolytic body (3) and a plurality of electrodes (5, 7) which is formed on the solid electrolytic body (3) and disposed opposite to each other with the solid electrolytic body (3) interposed therebetween, and the solid electrolytic body (3) includes an oxide-based lithium ion conductive solid electrolyte as a base material and contains oxide particles formed of a part of elements configuring the base material.

Abstract: An ultrasonic module includes a reception circuit adapted to receive a reception signal from an ultrasonic device, which receives an ultrasonic wave, to generate an echo signal, switching power supplies driven with a predetermined switching cycle, and adapted to supply the reception circuit with electrical power, and a phasing addition circuit adapted to perform an addition process on a first echo signal output when driving the reception circuit at a first drive timing in the switching cycle, and a second echo signal output when driving the reception circuit at a second drive timing delayed as much as a half cycle of a switching noise in the switching power supplies from the first drive timing.

Abstract: The pharmaceutical injection device includes a main body case, a cartridge holder, a latching receiver, a driver, and an interface component. The cartridge holder has a holding space and a holder latching component. The holding space is capable of holding a pharmaceutical cartridge. The latching receiver latches or releases the holder latching component according to whether the cartridge holder is closed or open. The driver automatically releases the latching of the latching receiver and the holder latching component. The interface component manually releases the latching of the latching receiver and the holder latching component by moving the latching receiver upon being subjected to external pressure. The driver or the interface component releases latching between the latching receiver and the holder latching component.

Abstract: The present invention relates to an antibody having a therapeutic effect on a tumor. That is, the invention relates to an antibody which binds to B7-H3 to exhibit an antitumor activity. An object of the invention is to provide a pharmaceutical having a therapeutic effect on a tumor. By obtaining an anti-B7-H3 antibody which binds to B7-H3 to exhibit an antitumor activity, a pharmaceutical composition for treating a tumor comprising the antibody and the like are obtained.

Abstract: An image processing apparatus including a region-of-interest decision unit that identifies an interest space region in which an object to be analyzed is likely to be present based on a distance image, which is shape information of an object space corresponding to a captured image to be analyzed acquired by a distance image sensor, to identify a region of interest in the captured image corresponding to the interest space region and an image analysis unit that performs different image analyses for the region of interest and other image regions.

Abstract: A pharmaceutical injection device may comprise a main body case in the interior of which a pharmaceutical syringe can be mounted; a drive means that is provided inside the main body case and pushes out the pharmaceutical inside the pharmaceutical syringe through a syringe needle; a cover that opens and closes an opening on the side of the main body case where the syringe needle is mounted; an outside air temperature sensor that measures a first temperature, which is the temperature outside the main body case; a display component; and a controller that controls the drive means and the display component and acquires the first temperature at predetermined intervals. When the cover is closed, the controller causes the display component to display information about the storage state of the pharmaceutical in the mounted pharmaceutical syringe on the basis of the first temperature.

Abstract: A pharmaceutical injection device may comprise a main body case having a cartridge holder, a piston that pushes out the pharmaceutical of a pharmaceutical cartridge held in the cartridge holder, a light emitting component, a light receiving component, and a controller. The light emitting component may shine light of different colors on the pharmaceutical cartridge disposed in the cartridge holder. The light receiving component receives light that has been shined from the light emitting component onto the pharmaceutical cartridge and reflected by the pharmaceutical cartridge. The controller may shine from the light emitting component and identify the type of pharmaceutical cartridge.

Abstract: A method capable of accurately measuring, in an object including a columnar shaft section and a tabular section projecting outward radially beyond an outer circumferential surface of the shaft section, a distribution of residual stress near a fillet surface interconnecting the shaft section and the tabular section. The method includes repeating a measurement cycle, which includes cutting the object to form a new cutting surface and measuring residual stress in a plurality of parts on the cutting surface. The cutting surface is a conical or cylindrical surface concentric with the axis of the shaft section, being through a reference position unchanged in the repeated measurement cycle. The reference position is desirably the center position of an arc of the fillet surface having the largest diameter on the central longitudinal cross-section of the object.

Abstract: An antibody exhibiting antitumor activity that binds to B7-H3, a functional fragment of the antibody, a pharmaceutical composition that includes the antibody or the functional fragment, methods for making the antibody or the functional fragment, methods for treating a tumor using the antibody or the functional fragment, and polynucleotides encoding the antibody or the functional fragment.